These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 26822024

  • 1. Eosinophilic Fasciitis and Acute Encephalopathy Toxicity from Pembrolizumab Treatment of a Patient with Metastatic Melanoma.
    Khoja L, Maurice C, Chappell M, MacMillan L, Al-Habeeb AS, Al-Faraidy N, Butler MO, Rogalla P, Mason W, Joshua AM, Hogg D.
    Cancer Immunol Res; 2016 Mar; 4(3):175-8. PubMed ID: 26822024
    [Abstract] [Full Text] [Related]

  • 2. Pembrolizumab versus Ipilimumab in Advanced Melanoma.
    Robert C, Schachter J, Long GV, Arance A, Grob JJ, Mortier L, Daud A, Carlino MS, McNeil C, Lotem M, Larkin J, Lorigan P, Neyns B, Blank CU, Hamid O, Mateus C, Shapira-Frommer R, Kosh M, Zhou H, Ibrahim N, Ebbinghaus S, Ribas A, KEYNOTE-006 investigators.
    N Engl J Med; 2015 Jun 25; 372(26):2521-32. PubMed ID: 25891173
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pembrolizumab for Treatment of Patients with Advanced or Unresectable Melanoma.
    Sullivan RJ, Flaherty KT.
    Clin Cancer Res; 2015 Jul 01; 21(13):2892-7. PubMed ID: 25931451
    [Abstract] [Full Text] [Related]

  • 5. Safety of pembrolizumab for the treatment of melanoma.
    Martin-Liberal J, Kordbacheh T, Larkin J.
    Expert Opin Drug Saf; 2015 Jun 01; 14(6):957-64. PubMed ID: 25927979
    [Abstract] [Full Text] [Related]

  • 6. A Rare Case of Pembrolizumab-Induced Uveitis in a Patient with Metastatic Melanoma.
    Hanna KS.
    Pharmacotherapy; 2016 Nov 01; 36(11):e183-e188. PubMed ID: 27716999
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A rapid response to pembrolizumab in a patient with metastatic melanoma.
    Bayo Calero J, Aviñó Tarazona V.
    Immunotherapy; 2017 Mar 01; 9(3):225-228. PubMed ID: 28231724
    [Abstract] [Full Text] [Related]

  • 9. Cutaneous Metastatic Melanoma Resembling a Halo Nevus, in the Setting of PD-1 Inhibition.
    Harvey NT, Millward M, Macgregor K, Bucat RP, Wood BA.
    Am J Dermatopathol; 2016 Dec 01; 38(12):e159-e162. PubMed ID: 27870733
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of the pharmacokinetics and metabolism of pembrolizumab in the treatment of melanoma.
    Longoria TC, Tewari KS.
    Expert Opin Drug Metab Toxicol; 2016 Oct 01; 12(10):1247-53. PubMed ID: 27485741
    [Abstract] [Full Text] [Related]

  • 11. Successful Anti-PD-1 Antibody Treatment in a Metastatic Melanoma Patient With Known Severe Autoimmune Disease.
    Maul LV, Weichenthal M, Kähler KC, Hauschild A.
    J Immunother; 2016 May 01; 39(4):188-90. PubMed ID: 27023060
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Association of Vitiligo With Tumor Response in Patients With Metastatic Melanoma Treated With Pembrolizumab.
    Hua C, Boussemart L, Mateus C, Routier E, Boutros C, Cazenave H, Viollet R, Thomas M, Roy S, Benannoune N, Tomasic G, Soria JC, Champiat S, Texier M, Lanoy E, Robert C.
    JAMA Dermatol; 2016 Jan 01; 152(1):45-51. PubMed ID: 26501224
    [Abstract] [Full Text] [Related]

  • 14. Spotlight on pembrolizumab in the treatment of advanced melanoma.
    Rajakulendran T, Adam DN.
    Drug Des Devel Ther; 2015 Jan 01; 9():2883-6. PubMed ID: 26082618
    [Abstract] [Full Text] [Related]

  • 15. ACUTE EXUDATIVE PARANEOPLASTIC POLYMORPHOUS VITELLIFORM MACULOPATHY DURING VEMURAFENIB AND PEMBROLIZUMAB TREATMENT FOR METASTATIC MELANOMA.
    Sandhu HS, Kolomeyer AM, Lau MK, Shields CL, Schuchter LM, Nichols CW, Aleman TS.
    Retin Cases Brief Rep; 2015 Jan 01; 13(2):103-107. PubMed ID: 28614138
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Eosinophilic fasciitis and metastatic choroïdal melanoma: a paraneoplastic syndrome?].
    Veyssier-Belot C, Zuech P, Lumbroso-Le Rouic L, Récanati G, Dendale R.
    Rev Med Interne; 2008 Dec 01; 29(12):1013-6. PubMed ID: 18617293
    [Abstract] [Full Text] [Related]

  • 20. Outcomes of patients with non-melanoma solid tumours receiving self-funded pembrolizumab at Chris O'Brien Lifehouse.
    Lomax AJ, Beith J, Bhadri V, Boyer M, Grimison P, Horvath LG, Kao S, Tattersall M, Thomas D, McNeil C.
    Intern Med J; 2016 Dec 01; 46(12):1392-1398. PubMed ID: 27554283
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.